SCHEMBL384883

SCHEMBL384883

C[N+]1(CCCC[N+]2(C)CCCCC2)CCCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 2/20 0.56
KDM4E B2RXH2 1/20 0.54
LMNA P02545 4/20 0.53
APOBEC3A P31941 2/20 0.53
APOBEC3G Q9HC16 2/20 0.53
KMT2A Q03164 2/20 0.53
TSHR P16473 2/20 0.48
CYP3A4 P08684 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
BLM P54132 1/20 0.48
PMP22 Q01453 1/20 0.48
CTDSP1 Q9GZU7 2/20 0.47
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
TP53 P04637 1/20 0.41
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL14913825 0.97 BBOX1 (0.54) BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G
SCHEMBL12638422 0.97 LMNA (0.57) BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G
SCHEMBL417495 0.97 LMNA (0.57) BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G
SCHEMBL3040478 0.97 LMNA (0.57) BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G
SCHEMBL923466 0.97 LMNA (0.57) BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G
SCHEMBL3043744 0.97 LMNA (0.57) BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G
Water SCHEMBL14914159 0.97 BBOX1 (0.54) BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G
SCHEMBL3037609 0.97 LMNA (0.57) BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G
SCHEMBL812356 0.97 BBOX1 (0.58) BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G
Water SCHEMBL23525630 0.94 LMNA (0.55) BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2766303-B1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RES & ENG CO (US) 2017-11-22 EP claimed
US-20160102590-A1 METHODS OF MAKING POROUS CRYSTALLINE MATERIALS AND THEIR USE IN HYDROCARBON SORPTION EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-04-14 US claimed
US-8916130-B2 Synthesis of MSE-framework type molecular sieves EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2014-12-23 US claimed
US-8679451-B2 Method for making aluminosilicate ZSM-12 CHEVRON U.S.A. INC. (US) 2014-03-25 US claimed
US-20130115163-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-05-09 US claimed
US-20110123433-A1 METHOD FOR MAKING ALUMINOSILICATE ZSM-12 CHEVRON U.S.A. INC. 2011-05-26 US claimed
WO-2022085774-A1 HYDROCARBON ADSORBENT AND HYDROCARBON ADSORPTION METHOD 東ソー株式会社 2022-04-28 WO disclosed
US-10226319-B2 Removal of occluded alkali metal cations from MSE-framework type molecular sieves EXXONMOBIL RESEARCH AND ENGINEERING (US) 2019-03-12 US disclosed
US-20180161139-A1 REMOVAL OF OCCLUDED ALKALI METAL CATIONS FROM MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2018-06-14 US disclosed
US-9896344-B2 Removal of occluded alkali metal cations from MSE-framework type molecular sieves EXXONMOBILE RESEARCH AND ENGINEERING COMPANY (US) 2018-02-20 US disclosed
EP-2766303-B1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RES & ENG CO (US) 2017-11-22 EP disclosed
EP-2766303-B1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RES & ENG CO (US) 2017-11-22 EP disclosed
US-20160101985-A1 REMOVAL OF OCCLUDED ALKALI METAL CATIONS FROM MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-04-14 US disclosed
WO-2013055871-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-04-18 WO disclosed
US-8101811-B2 Process for isomerizing a hydrocarbonaceous feedstock using aluminosilicate ZSM-12 CHEVRON U.S.A. INC. (US) 2012-01-24 US disclosed
US-8101811-B2 Process for isomerizing a hydrocarbonaceous feedstock using aluminosilicate ZSM-12 CHEVRON U.S.A. INC. (US) 2012-01-24 US disclosed
US-20110124940-A1 PROCESS FOR ISOSOMERIZING A HYDROCARBONACEOS FEESTOCK USING ALUMINOSILICATE ZSM-12 CHEVRON U.S.A. INC. 2011-05-26 US disclosed
US-20110124940-A1 PROCESS FOR ISOSOMERIZING A HYDROCARBONACEOS FEESTOCK USING ALUMINOSILICATE ZSM-12 CHEVRON U.S.A. INC. 2011-05-26 US disclosed
US-20110123433-A1 METHOD FOR MAKING ALUMINOSILICATE ZSM-12 CHEVRON U.S.A. INC. 2011-05-26 US disclosed
US-20110123433-A1 METHOD FOR MAKING ALUMINOSILICATE ZSM-12 CHEVRON U.S.A. INC. 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124940-A1 PROCESS FOR ISOSOMERIZING A HYDROCARBONACEOS FEESTOCK USING ALUMINOSILICATE ZSM-12 TCF12, ZKSCAN2, IKZF2 BBOX1 247/4885KDM4E 2261/4885LMNA 1767/4885
US-20130115163-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES MRPS2, UFM1, B2M BBOX1 3456/4885KDM4E 453/4885LMNA 3760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.